Work

Crenolanib Is A Highly Potent, Selective, FLT3 TKI with Activity Against D835 Mutations

Year: 2012

Type: article

Source: Blood

DOI: 10.1182/blood.v120.21.1341.1341

Authors: Allison Galanis, Trivikram Rajkhowa, Chaitanya Muralidhara, Abhijit Ramachandran, Mark J. Levis

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Arog Pharmaceuticals (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554518403

FWCI: 0.409

Cites:

Cited by: 5

Related to: 10